Login
$TRVI
$13.35 +$0.84 (6.71%) Close

$TRVI 4/A SEC Filings

Filed On Filing
01 Jul 2022 Form 4/A: Vanlent Anne, Director

Granted 20,000 Nonstatutory Stock Option (right to buy)

01 Jul 2022 Form 4/A: Meeker David P, Director

Granted 20,000 Nonstatutory Stock Option (right to buy)

01 Jul 2022 Form 4/A: Heffernan Michael Thomas, Director

Granted 20,000 Nonstatutory Stock Option (right to buy)

01 Jul 2022 Form 4/A: Colangelo Dominick, Director

Granted 20,000 Nonstatutory Stock Option (right to buy)

01 Jul 2022 Form 4/A: Cassella James V, Director

Granted 20,000 Nonstatutory Stock Option (right to buy)

01 Jul 2022 Form 4/A: Sciascia Thomas, Chief Medical Officer

Granted 110,000 Stock Option (right to buy)

01 Jul 2022 Form 4/A: Forbes William P, Chief Development Officer

Granted 137,500 Stock Option (right to buy)

01 Jul 2022 Form 4/A: Good Jennifer L, Director

Granted 275,000 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support